Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Korang, S. K. von Rohden, E. Veroniki, A. A. Ong, G. Ngalamika, O. Siddiqui, F. Juul, S. Nielsen, E. E. Feinberg, J. B. Petersen, J. J. Legart, C. Kokogho, A. Maagaard, M. Klingenberg, S. Thabane, L. Bardach, A. Ciapponi, A. Thomsen, A. R. Jakobsen, J. C. Gluud, C.

Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Cortés-Sarabia, K. Gutiérrez-Torres, M. Mendoza-Renteria, E. M. Leyva-Vázquez, M. A. Vences-Velázquez, A. Hernández-Sotelo, D. Beltrán-Anaya, F. O. Del Moral-Hernández, O. Illades-Aguiar, B.

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Martinez-Reviejo, R. Tejada, S. Adebanjo, G. A. R. Chello, C. Machado, M. C. Parisella, F. R. Campins, M. Tammaro, A. Rello, J.

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Alhendyani, F. Jolly, K. Jones, L. L.

Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis

  • Healthcare workers
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Nanishi, E. Levy, O. Ozonoff, A.

Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Gao, H. Lau, E. H. Y. Cowling, B. J.

Waning Immunity after Receipt of Pertussis, Diphtheria, Tetanus, and Polio-Related Vaccines: A Systematic Review and Meta-analysis

  • All age groups
  • Pertussis
  • Diphtheria
  • Tetanus
  • Poliomyelitis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kitamura, N. Bahkali, K. Chem, E. D. Quilty, B. J. Edwards, T. Toizumi, M. Yoshida, L. M.

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis

  • All age groups
  • Diphtheria
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2022 ∙ Paybast, S. Emami, A. Baghalha, F. Naser Moghadasi, A.

Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Romate, J. Rajkumar, E. Gopi, A. Abraham, J. Rages, J. Lakshmi, R. Jesline, J. Bhogle, S.

What Contributes to COVID-19 Vaccine Hesitancy? A Systematic Review of the Psychological Factors Associated with COVID-19 Vaccine Hesitancy

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Mitchell, H. Lim, R. Gill, P. K. Dhanoa, J. Dubé, È Bettinger, J. A.

What do adolescents think about vaccines? Systematic review of qualitative studies

  • Adolescents
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...